Results 101 to 110 of about 50,123 (191)

The Current Landscape and Future Prospects of Vaccine Manufacturing in Africa: Challenges, Innovations, and Opportunities: A Narrative Review

open access: yesHealth Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aims Africa has significant challenges in meeting its vaccination needs, including inadequate manufacturing capacity, infrastructure deficiencies, a scarcity of experienced personnel, regulatory hurdles, restricted access to technology and intellectual property.
Courage Chandipwisa   +3 more
wiley   +1 more source

Society for Maternal‐Fetal Medicine Special Statement: Revised updated checklist for antepartum care of pregestational diabetes mellitus

open access: yesPregnancy, Volume 2, Issue 2, March 2026.
Abstract Pregestational diabetes mellitus (type 1 or type 2 diabetes) is associated with increased risks of both maternal and neonatal complications due to maternal hyperglycemia and underlying chronic conditions and comorbidities. To reduce or mitigate these risks, numerous interventions are recommended at various stages of pregnancy.
Society for Maternal‐Fetal Medicine (SMFM)   +5 more
wiley   +1 more source

Clinical and evidence-based considerations for choosing a pneumococcal conjugate vaccine in India: A narrative review

open access: yesHuman Vaccines & Immunotherapeutics
Immunization plays a crucial role in protecting children from life-threatening conditions such as pneumococcal disease. Pneumococcal disease can affect multiple organ systems and manifest as an invasive or noninvasive disease.
Vijay Yewale   +4 more
doaj   +1 more source

Immunization Update, April 2008, Vol. 1, no. 7 [PDF]

open access: yes, 2008
Monthly newsletter for the Iowa Department of Public ...

core  

State of pneumococcal vaccine immunity

open access: yesHuman Vaccines & Immunotherapeutics
Like the other invasive encapsulated bacteria, Streptococcus pneumoniae is also covered with a polysaccharide structure. Infants and elderly are most vulnerable to the invasive and noninvasive diseases caused by S. pneumoniae. Although antibodies against
Mustafa Akkoyunlu
doaj   +1 more source

Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention Strategies

open access: yesEuropean Journal of Haematology, Volume 116, Issue 3, Page 204-214, March 2026.
ABSTRACT Infections remain a leading cause of morbidity and mortality in patients with chronic lymphocytic leukemia (CLL), reflecting both intrinsic immune dysfunction and therapy‐related immunosuppression. The pathogenesis of immunodeficiency in CLL is multifactorial: neoplastic B cells impair humoral immunity, T cells are functionally exhausted, and ...
Enrica Antonia Martino   +10 more
wiley   +1 more source

Identification and Quantification of a Pneumococcal Cell Wall Polysaccharide by Antibody-Enhanced Chromatography Assay

open access: yesVaccines
Multivalent pneumococcal vaccines have been developed successfully to combat invasive pneumococcal diseases (IPD) and reduce the associated healthcare burden.
James Z. Deng   +10 more
doaj   +1 more source

Pneumonia Risk in Institutionalized Older Adults With Severe Functional Dependency: An Exploratory Analysis Using Standardized Long‐Term Care Assessment Data

open access: yesGeriatrics &Gerontology International, Volume 26, Issue 3, March 2026.
A simple, routinely collected long‐term care assessment identified key predictors of pneumonia—male sex, hypoalbuminemia, impaired cognitive ability for daily decision‐making, and weight loss of ≥ 3% over the past 6 months. Tracking short‐term weight loss provides a practical risk marker for institutionalized older adults with severe functional ...
Yuichi Ohteru   +5 more
wiley   +1 more source

Sex Differences in Lung Immunity

open access: yesImmunological Reviews, Volume 338, Issue 1, March 2026.
ABSTRACT Biological sex has a significant impact on how the immune system develops and responds to foreign and self‐antigens. Sex differences exist in innate and adaptive immune cells, both at homeostasis and in the context of infection and inflammatory diseases such as asthma, cancer, and autoimmune disorders.
Franz Puttur, Clare M. Lloyd
wiley   +1 more source

The “Reducing Inflammation for Greater Health Trial (RIGHT)” Study—Concept, Rationale, and Design

open access: yesJournal of the American Geriatrics Society, Volume 74, Issue 3, Page 636-647, March 2026.
ABSTRACT The Reducing Inflammation for Greater Health Trial's (RIGHT) study is a single‐center, randomized, double‐blind, placebo‐controlled trial designed to test whether clazkizumab, an interleukin‐6 (IL‐6) inhibitor, can improve or slow decline in physical, cognitive, and vascular function in older adults, when compared to a placebo.
Sebastian E. Sattui   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy